Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
diabetic neuropathy
MedTech
FDA OKs Neuralace’s nerve stimulation tech for diabetes pain
The original FDA nod for Neuralace's Axon Therapy for nerve pain came after a decade of R&D. The road to its next regulatory nod was much shorter.
Andrea Park
Jan 11, 2024 12:39pm
Boston Sci spinal cord stimulators nab diabetic neuropathy nod
Oct 12, 2023 10:44am
Nevro's neurostim cuts diabetic neuropathy pain by 80%: study
Aug 16, 2023 11:46am
Case builds for NeuroMetrix, Sudoscan devices
Jun 12, 2023 12:47pm
Nonessential amino acid plays an essential role in neuropathy
Jan 30, 2023 9:10am
FDA OKs DyAnsys’ neurostimulator for diabetes pain
Jul 18, 2022 9:25am